Eagle Pharmaceuticals Inc (EGRX)
4.16
-0.08
(-1.89%)
USD |
NASDAQ |
Apr 26, 16:00
4.15
-0.01
(-0.24%)
After-Hours: 20:00
Eagle Pharmaceuticals Cash from Operations (TTM): -9.318M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -9.318M |
March 31, 2023 | 33.80M |
December 31, 2022 | 50.70M |
September 30, 2022 | 21.22M |
June 30, 2022 | 35.53M |
March 31, 2022 | 1.13M |
December 31, 2021 | 28.22M |
September 30, 2021 | 39.90M |
June 30, 2021 | 44.46M |
March 31, 2021 | 56.82M |
December 31, 2020 | 49.50M |
September 30, 2020 | 26.54M |
June 30, 2020 | 31.52M |
March 31, 2020 | 32.96M |
December 31, 2019 | 55.99M |
September 30, 2019 | 97.30M |
June 30, 2019 | 90.37M |
March 31, 2019 | 73.64M |
December 31, 2018 | 52.38M |
September 30, 2018 | 40.20M |
Date | Value |
---|---|
June 30, 2018 | 44.40M |
March 31, 2018 | 76.28M |
December 31, 2017 | 58.92M |
September 30, 2017 | 72.55M |
June 30, 2017 | 77.84M |
March 31, 2017 | 37.66M |
December 31, 2016 | 53.21M |
September 30, 2016 | -3.147M |
June 30, 2016 | -22.95M |
March 31, 2016 | -32.45M |
December 31, 2015 | -9.718M |
September 30, 2015 | -0.794M |
June 30, 2015 | -1.287M |
March 31, 2015 | 6.167M |
December 31, 2014 | -21.74M |
September 30, 2014 | -13.84M |
June 30, 2014 | -7.030M |
March 31, 2014 | -5.097M |
December 31, 2013 | -4.047M |
September 30, 2013 | -5.879M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.318M
Minimum
Jun 2023
97.30M
Maximum
Sep 2019
40.39M
Average
35.53M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
Inspire Medical Systems Inc | 24.65M |
Soligenix Inc | -8.604M |
Marinus Pharmaceuticals Inc | -118.00M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |